Header
about | contact | sitemap | home
Mesothelioma

What is Mesothelioma

Pleural Mesothelioma

Peritoneal Mesothelioma

Pericardial Mesothelioma

Risk Factors

Symptoms

Stages

Asbestosis

Mesothelioma Treatment

Treatment Options

Treatment by Stage

Chemotherapy

Medical Procedures

Imaging Scans

Types of Doctors

Clinical Trials

Clinical Trials Directory

Cancer Care Centers

Mesothelioma Specialists

Alternative Therapies

Asbestos

Types of Asbestos

Asbestos Industry

Asbestos History

In the Workplace

Asbestos Legislation

Asbestos Removal

Legal Help

Your Legal Rights

Choosing an Attorney

The Legal Process

Evaluating Your Case

Chemo Combination Improves Meso Survival Rate

February 9, 2007 - A recently completed large multi-center study demonstrates that patients with mesothelioma have a higher survival rate when treated with a combination of two cancer drugs.

According to an article in the current issue of The Cochrane Library, a publication of The Cochrane Collaboration, an international organization that evaluates medical research, people treated with both pemetrexed and cisplatin, along with the vitamin supplements folic acid and B12, survived an average of nearly 3 months longer than those patients treated with just cisplatin alone. 

A press release notes that the researchers, led by Dr. John Green at the Clatterbridge Center for Oncology in England, reviewed a study of 448 patients with advanced mesothelioma who were treated with either the single drug or the combination.

"Pemetrexed used in combination with cisplatin significantly increases the length of survival, when compared with cisplatin alone," the researchers say. "Further research is needed into the optimum treatment regimen for pleural mesothelioma."

Data was gathered from 20 treatment centers in Europe, the Americas, Australia and Asia. Eighty-one percent of the patients were men, with an average age of 61.  The patients agreed that their quality of life had also improved as a result of the drug combination, thanks to a reduction in pain, coughing, fatigue, and other common symptoms of malignant pleural mesothelioma.

“It is a personal matter as to whether the survival increase for patients receiving the two drugs is worthwhile,” said Dr. Daniel Baram, M.D., a pulmonologist at the Lung Cancer Evaluation Center at the State University of New York. "It depends in large part on the patient. A 2.8-month mean survival increase means that some patients may get even more than that, though some people will get less. Many, if not most, patients when faced with a disease with a very bad prognosis are often willing to undergo aggressive therapy, although the toxicity is serious and potentially life-threatening."

 

Free Mesothelioma Information Pack

Mesothelioma Packet Enter your information to receive a free mesothelioma information packet in 24 hours.

First Name:

Last Name:

Address:

City:

State:

Zip:

Telephone:

Email Address:

Is it possible you
or someone you
know has
mesothelioma?
Yes   No

frequently asked questions
glossary
job sites

Shipyards

Metal Works

Powerhouses

Other Job Sites

mesothelioma

Current News

Archive

California's state rock causes a legislative stir

Many believe that the asbestos found in serpentine makes it a bad choice for a state icon

Ser ...

Campaigning for an official Mesothelioma Awareness Day The next step in campaigning against the adverse health impacts of asbestos exposure and its resulting disease ...

David King family campaigns to raise awareness of mesothelioma cancer

When David King died of malignant mesothelioma at the age of ...

Secretary at Iron Company Develops Mesothelioma

Group Offers Asbestos Removal Kit

Labor Union Searching for Former Shipyard Workers

Support

Coping Process

Managing Pain

Nutrition

For the Caregiver

Feelings After Diagnosis

Dealing with Symptoms

Practical Issues

Relationship Issues

Wills and DNRs

Resources